In November last year, the Financial Times discussed some of the characteristics of the transformation of the Chinese pharmaceutical industry at the “2018 Pharmaceutical & Biotechnology Summit” held in London. At the meeting, the host threw out a poll of “When do you think China might become an important… Continue Reading The new road of Chinese pharmaceutical companies
Helping clients improve the efficiency of clinical development will continue to be the core competencies of clinical CRO companies in 2018 and in the future. Pharmaceutical companies will unremittingly find new ways to shorten the development cycle and reduce costs. Therefore, CRO companies that rely on professional skills rather than… Continue Reading Clinical CRO Industry Trends in 2018
In April 17th and 19th, the medicine magic cube &GLG Geli group held the “China contract research organisations (CRO) market and the Chinese pharmaceutical CRO industry atlas conference” in Beijing and Shanghai respectively. Zhou Liyun, the founder of the medicine magic cube, combed the scale of the CRO industry, the… Continue Reading Is it a wise move for CRO companies to get involved in new drug research and development?